Cronos (CRON) Income from Non-Controlling Interests (2019 - 2026)

Cronos (CRON) recorded quarterly Income from Non-Controlling Interests of $1.1 million in Q1 2026, down 17.74% quarter-over-quarter from $1.3 million in Q4 2025, and down 24.46% on a YoY basis from $1.4 million in Q1 2025.

Cronos (CRON) Income from Non-Controlling Interests (2019 - 2026) Analysis & Trends

Cronos' Income from Non-Controlling Interests history runs 8 years deep, the most recent figure standing at $1.1 million for Q1 2026.

  • In Q1 2026, Income from Non-Controlling Interests fell 24.46% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $5.3 million (up 468.74% YoY), while the FY2025 annual figure was $6.5 million, up 305.23% from the prior year.
  • Income from Non-Controlling Interests was $1.1 million for Q1 2026 at Cronos, down from $1.3 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $1.6 million in Q3 2025 to a low of -$1.9 million in Q4 2024.
  • Historically, Income from Non-Controlling Interests has averaged $166764.7 across 5 years, with a median of -$87000.0 in 2023.
  • The sharpest annual moves came in 2024 and 2025: Income from Non-Controlling Interests slumped 1001.73% in 2024, then soared 2018.97% in 2025.
  • A 5-year view of Income from Non-Controlling Interests shows it stood at -$16000.0 in 2022, then sank by 981.25% to -$173000.0 in 2023, then plunged by 1001.73% to -$1.9 million in 2024, then surged by 169.52% to $1.3 million in 2025, then retreated by 17.74% to $1.1 million in 2026.
  • The last three Income from Non-Controlling Interests figures came in at $1.1 million (Q1 2026), $1.3 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 22.56 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Cronos 1.06 Bn 284.85 Mn 19.15 Mn 1.09 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.09 Mn
Dec 31, 2025 1.33 Mn
Sep 30, 2025 1.63 Mn
Jun 30, 2025 1.23 Mn
Mar 31, 2025 1.44 Mn
Dec 31, 2024 -1.91 Mn
Sep 30, 2024 -1.03 Mn
Jun 30, 2024 58,000.00
Mar 31, 2024 -243,000.00
Dec 31, 2023 -173,000.00
Sep 30, 2023 -128,000.00
Jun 30, 2023 -87,000.00
Mar 31, 2023 -88,000.00
Dec 31, 2022 -16,000.00
Sep 30, 2022 105,000.00
Jun 30, 2022 -117,000.00
Mar 31, 2022 -261,000.00
Dec 31, 2021 62,000.00
Sep 30, 2021 -250,000.00
Jun 30, 2021 -394,000.00